Literature DB >> 19056487

Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.

Kristy Boyle1, Jian-Guo Zhang, Sandra E Nicholson, Evelyn Trounson, Jeffery J Babon, Edward J McManus, Nicos A Nicola, Lorraine Robb.   

Abstract

The mechanism by which Suppressor of Cytokine Signaling-3 (SOCS3) negatively regulates cytokine signaling has been widely investigated using over-expression studies in cell lines and is thought to involve interactions with both the gp130 receptor and JAK1. Here, we compare the endogenous JAK/STAT signaling pathway downstream of Leukemia Inhibitory Factor (LIF) signaling in wild type (WT) Embryonic Stem (ES) cells and in ES cells lacking either the entire Socs3 gene or bearing a truncated form of SOCS3 (SOCS3DeltaSB) lacking the C-terminal SOCS box motif (SOCS3(DeltaSB/DeltaSB)). In SOCS3(DeltaSB/DeltaSB) cells phosphorylated JAK1 accumulated at much higher levels than in WT cells or even cells lacking SOCS3 (SOCS3(-/-)). In contrast enhanced activation of STAT3 and SHP2 was seen in SOCS3(-/-) cells. Size exclusion chromatography of cell extracts showed that in unstimulated cells, JAK1 was exclusively associated with receptors but following cytokine stimulation hyperphosphorylated JAK1 (pJAK1) appeared to dissociate from the receptor complex in a manner independent of SOCS3. In WT and SOCS3(DeltaSB/DeltaSB) cells SOCS3 was associated with pJAK1. The data suggest that dissociation of activated JAK1 from the receptor results in separate targeting of JAK1 for proteasomal degradation through a mechanism dependent on the SOCS3 SOCS box thus preventing further activation of STAT3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056487      PMCID: PMC3437335          DOI: 10.1016/j.cellsig.2008.11.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  49 in total

1.  SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.

Authors:  J Schmitz; M Weissenbach; S Haan; P C Heinrich; F Schaper
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

2.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

3.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.

Authors:  Seiji Okada; Masaya Nakamura; Hiroyuki Katoh; Tamaki Miyao; Takuya Shimazaki; Ken Ishii; Junichi Yamane; Akihiko Yoshimura; Yukihide Iwamoto; Yoshiaki Toyama; Hideyuki Okano
Journal:  Nat Med       Date:  2006-06-18       Impact factor: 53.440

4.  Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival.

Authors:  D Duval; B Reinhardt; C Kedinger; H Boeuf
Journal:  FASEB J       Date:  2000-08       Impact factor: 5.191

5.  Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B.

Authors:  David Cappellen; Ngoc-Hong Luong-Nguyen; Sandrine Bongiovanni; Olivier Grenet; Christoph Wanke; Mira Susa
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

6.  c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3.

Authors:  Kate D Sutherland; François Vaillant; Warren S Alexander; Tim M Wintermantel; Natasha C Forrest; Sheridan L Holroyd; Edward J McManus; Gunther Schutz; Christine J Watson; Lewis A Chodosh; Geoffrey J Lindeman; Jane E Visvader
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

7.  Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.

Authors:  R J Rigby; J G Simmons; C J Greenhalgh; W S Alexander; P K Lund
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

8.  The dual function of hepatic SOCS3 in insulin resistance in vivo.

Authors:  Takehiro Torisu; Naoichi Sato; Daigo Yoshiga; Takashi Kobayashi; Tomoko Yoshioka; Hiroyuki Mori; Mitsuo Iida; Akihiko Yoshimura
Journal:  Genes Cells       Date:  2007-02       Impact factor: 1.891

9.  SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis.

Authors:  Ben A Croker; Donald Metcalf; Lorraine Robb; Wei Wei; Sandra Mifsud; Ladina DiRago; Leonie A Cluse; Kate D Sutherland; Lynne Hartley; Emily Williams; Jian-Guo Zhang; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

10.  Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation.

Authors:  Serge Haan; Paul Ferguson; Ulrike Sommer; Meena Hiremath; Daniel W McVicar; Peter C Heinrich; James A Johnston; Nicholas A Cacalano
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

View more
  27 in total

Review 1.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

2.  A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

Authors:  Liang Li; Hardik Modi; Tinisha McDonald; John Rossi; Jiing-Kuan Yee; Ravi Bhatia
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

3.  Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways.

Authors:  Maria Abildgaard Steffensen; Christina Fenger; Jeanette Erbo Christensen; Carina Krogsgaard Jørgensen; Maria Rosaria Bassi; Jan Pravsgaard Christensen; Bente Finsen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

4.  SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF.

Authors:  Yong Li; Mei-Fang Han; Wei-Na Li; Ai-Chao Shi; Yuan-Ya Zhang; Hong-Yan Wang; Fa-Xi Wang; Lan Li; Ting Wu; Lin Ding; Tao Chen; Wei-Ming Yan; Xiao-Ping Luo; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

Review 5.  Inhibition of IL-6 family cytokines by SOCS3.

Authors:  Jeffrey J Babon; Leila N Varghese; Nicos A Nicola
Journal:  Semin Immunol       Date:  2014-01-10       Impact factor: 11.130

6.  CRISPR-UMI: single-cell lineage tracing of pooled CRISPR-Cas9 screens.

Authors:  Georg Michlits; Maria Hubmann; Szu-Hsien Wu; Gintautas Vainorius; Elena Budusan; Sergei Zhuk; Thomas R Burkard; Maria Novatchkova; Martin Aichinger; Yiqing Lu; John Reece-Hoyes; Roberto Nitsch; Daniel Schramek; Dominic Hoepfner; Ulrich Elling
Journal:  Nat Methods       Date:  2017-10-16       Impact factor: 28.547

Review 7.  Suppression of cytokine signaling: the SOCS perspective.

Authors:  Edmond M Linossi; Jeffrey J Babon; Douglas J Hilton; Sandra E Nicholson
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

8.  Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signaling.

Authors:  Jonathan T Lei; Tuhina Mazumdar; Margarita Martinez-Moczygemba
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

Review 9.  Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor.

Authors:  Hiroyuki Hirai; Peter Karian; Nobuaki Kikyo
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

Review 10.  SOCS1 and SOCS3 in the control of CNS immunity.

Authors:  Brandi J Baker; Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  Trends Immunol       Date:  2009-07-28       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.